Ascension logo

Ascension

Crunchbase
Pitchbook
Crunchbase

Deals on record

6

Common Fundraising Type

Seed

Cala Health logo
Cala Health

Bioelectronic

Vertex Growth Fund logo
TriVentures logo
Reimagined Ventures logo
OSF Ventures logo
Peak6 logo
Nexus NeuroTech Ventures logo
Lux Capital logo
Lightstone logo

Cala Health develops non-invasive, FDA-cleared wearable devices for hand tremor relief, focusing on essential tremor and Parkinson's disease.

Equity
$50M
12/09/2024
Article
Round logo
Round

Fintech

Round is a fintech company that simplifies treasury management for startups by consolidating banking, treasury, and cash management into a single platform.

Seed
$2.1M
10/08/2024
Article
CSA Medical logo
CSA Medical

Medical device

TVM Capital Life Science logo
Yonjin Ventures logo
SV Health Investors logo
Intersouth Partners logo
First Analysis logo
Ascension Ventures logo
Blue Heron logo

CSA Medical Inc. develops and commercializes the RejuvenAir System, a medical device designed to treat chronic bronchitis.

Series D
$53M
09/09/2024
Article
Hurr logo
Hurr

Fashion rental platform

Praetura Ventures logo
Octopus Ventures logo
D4 Ventures logo
Ascension logo

Hurr is a London-based fashion rental platform offering a peer-to-peer marketplace and white-label SaaS solutions, collaborating with major retailers to provide sustainable clothing options.

Equity
$10M
12/19/2023
Article
Censys logo
Censys

Cybersecurity

Intel Capital logo
GV logo
Greylock logo
Four Rivers Partners logo
Decibel Partners logo
Ascension Ventures logo

Censys is a cybersecurity company that provides customers with insights about critical internet-connected infrastructure and offers tools for monitoring and analyzing internet hosts and services, with a focus on threat hunting and triaging exploits.

Hybrid C
$75M
10/24/2023
Article
Kuano logo
Kuano

Drug Discovery

o2h Ventures logo
Mercia Ventures logo
Meltwind Advisory logo
Ascension Ventures logo
ACF Investors logo

Kuano is a drug discovery company that uses a quantum simulation platform to model enzymes in their dynamic state for more precise drug design, with a focus on diseases like bowel cancer and lymphoma.

Seed
$2.2M
09/13/2023
Article